Lindsay E. King

864 total citations
15 papers, 542 citations indexed

About

Lindsay E. King is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Lindsay E. King has authored 15 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Lindsay E. King's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Biosimilars and Bioanalytical Methods (8 papers) and Advanced Biosensing Techniques and Applications (4 papers). Lindsay E. King is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Biosimilars and Bioanalytical Methods (8 papers) and Advanced Biosensing Techniques and Applications (4 papers). Lindsay E. King collaborates with scholars based in United States, United Kingdom and Denmark. Lindsay E. King's co-authors include Ago Ahene, John Kamerud, Marian Kelley, Jihong Yang, Jean W. Lee, Hossein Salimi-Moosavi, Jianfeng Lü, Heather Myler, Meina Tang and Alison Betts and has published in prestigious journals such as Scientific Reports, Journal of Immunological Methods and Osteoarthritis and Cartilage.

In The Last Decade

Lindsay E. King

15 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindsay E. King United States 11 308 307 274 127 43 15 542
Heather Myler United States 15 410 1.3× 384 1.3× 403 1.5× 145 1.1× 10 0.2× 30 750
Ralph Adams United Kingdom 11 188 0.6× 166 0.5× 218 0.8× 99 0.8× 57 1.3× 13 452
Mengmeng Wang China 14 346 1.1× 216 0.7× 162 0.6× 61 0.5× 10 0.2× 41 575
Marianne Scheel Fjording Denmark 11 303 1.0× 45 0.1× 238 0.9× 125 1.0× 45 1.0× 17 610
Cheng‐Pang Hsu United States 9 396 1.3× 99 0.3× 151 0.6× 197 1.6× 10 0.2× 9 574
Ziwei Huang China 14 237 0.8× 53 0.2× 154 0.6× 134 1.1× 11 0.3× 34 582
Stéphane Olland United States 11 524 1.7× 137 0.4× 169 0.6× 175 1.4× 29 0.7× 16 761
Wouter Pos Netherlands 13 306 1.0× 86 0.3× 597 2.2× 135 1.1× 16 0.4× 18 901
Pier Paolo Olimpieri Italy 13 324 1.1× 203 0.7× 73 0.3× 42 0.3× 17 0.4× 33 541
Paul Rhyne United States 11 146 0.5× 38 0.1× 144 0.5× 197 1.6× 24 0.6× 19 441

Countries citing papers authored by Lindsay E. King

Since Specialization
Citations

This map shows the geographic impact of Lindsay E. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay E. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay E. King more than expected).

Fields of papers citing papers by Lindsay E. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsay E. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay E. King. The network helps show where Lindsay E. King may publish in the future.

Co-authorship network of co-authors of Lindsay E. King

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsay E. King. A scholar is included among the top collaborators of Lindsay E. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsay E. King. Lindsay E. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sivakumar, Pitchumani, Michelle Saul, Douglas S. Robinson, Lindsay E. King, & Neeta B. Amin. (2024). SomaLogic proteomics reveals new biomarkers and provides mechanistic, clinical insights into Acetyl coA Carboxylase (ACC) inhibition in Non-alcoholic Steatohepatitis (NASH). Scientific Reports. 14(1). 17072–17072. 7 indexed citations
2.
Atkuri, Kondala R., et al.. (2023). Mass cytometry for the multiplexed quantification and characterization of target expression on circulating cells in whole blood. Cytometry Part A. 103(8). 631–645. 1 indexed citations
3.
Jones, Hannah M., Zhiwei Zhang, Paul Jasper, et al.. (2019). A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics FromIn VitroData. CPT Pharmacometrics & Systems Pharmacology. 8(10). 738–747. 35 indexed citations
4.
King, Lindsay E.. (2016). Parallelism Experiments in Biomarker Ligand-Binding Assays to Assess Immunological Similarity. Bioanalysis. 8(23). 2387–2391. 10 indexed citations
5.
Clark, Tracey, Phillip D. Yates, Alison Joyce, et al.. (2016). Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform. The AAPS Journal. 18(5). 1300–1308. 11 indexed citations
6.
Betts, Alison, Nahor Haddish‐Berhane, John Tolsma, et al.. (2016). Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin. The AAPS Journal. 18(5). 1101–1116. 48 indexed citations
7.
King, Lindsay E., et al.. (2015). Antibody–Drug Conjugates Nonclinical Support: from Early to Late Nonclinical Bioanalysis Using Ligand-Binding Assays. Bioanalysis. 7(13). 1605–1617. 21 indexed citations
8.
9.
Shah, Dhaval K., Lindsay E. King, Xiaogang Han, et al.. (2014). A Priori Prediction of Tumor Payload Concentrations: Preclinical Case Study with an Auristatin-Based Anti-5T4 Antibody-Drug Conjugate. The AAPS Journal. 16(3). 452–463. 45 indexed citations
10.
Kelley, Marian, Ago Ahene, Boris Gorovits, et al.. (2013). Theoretical Considerations and Practical Approaches to Address the Effect of Anti-drug Antibody (ADA) on Quantification of Biotherapeutics in Circulation. The AAPS Journal. 15(3). 646–658. 47 indexed citations
11.
Bowman, Christopher, et al.. (2012). Embryo-fetal distribution of a biopharmaceutical IgG2 during rat organogenesis. Reproductive Toxicology. 34(1). 66–72. 8 indexed citations
12.
King, Lindsay E., et al.. (2012). Practical quantitative and kinetic applications of bio-layer interferometry for toxicokinetic analysis of a monoclonal antibody therapeutic. Journal of Immunological Methods. 379(1-2). 30–41. 13 indexed citations
13.
14.
King, Lindsay E., et al.. (2007). Human kallikrein 10 ELISA development and validation in breast cancer sera. Clinical Biochemistry. 40(13-14). 1057–1062. 9 indexed citations
15.
Janusz, Michael J., Christopher B. Little, Lindsay E. King, et al.. (2004). Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration. Osteoarthritis and Cartilage. 12(9). 720–728. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather Myler Breakdown of academic impact, for papers by Ralph Adams Breakdown of academic impact, for papers by Mengmeng Wang Breakdown of academic impact, for papers by Marianne Scheel Fjording Breakdown of academic impact, for papers by Cheng‐Pang Hsu Breakdown of academic impact, for papers by Ziwei Huang Breakdown of academic impact, for papers by Stéphane Olland Breakdown of academic impact, for papers by Wouter Pos Breakdown of academic impact, for papers by Pier Paolo Olimpieri Breakdown of academic impact, for papers by Paul Rhyne
Rankless by CCL
2026